Je selectiemandje is leeg.
Maak een selectie van ETF's die je wilt vergelijken.
Voeg een ETF toe door op "Vergelijk" te klikken op een ETF-profiel of door een ETF aan te vinken in de ETF-zoekfunctie.
Global X Genomics & Biotechnology UCITS ETF
ISIN IE00BM8R0N95
|Ticker GNOM
TER
0,50% p.a.
Distributiebeleid
Accumulerend
Replicatie
Fysiek
Fondsgrootte
EUR 28 m
Startdatum
2 november 2021
Bedrijven
49
Overzicht
Beschrijving
The Global X Genomics & Biotechnology UCITS ETF seeks to track the Solactive Genomics index. The Solactive Genomics index tracks companies active in the fields of genomics and biotechnology.
Grafiek
Basis
Data
| Index | Solactive Genomics |
| Investeringsfocus | Aandelen, Wereld, Gezondheidszorg |
| Fondsgrootte | EUR 28 m |
| Totale kostenratio (TER) | 0,50% p.a. |
| Replicatie | Fysiek (Volledige replicatie) |
| Juridische structuur | ETF |
| Beleggingsaanpak | Langdurig |
| Duurzaamheid | No |
| Valuta van het fonds | USD |
| Valutarisico | Valuta niet gedekt |
| Volatiliteit 1 jaar (in EUR) | 36,70% |
| Startdatum/Noteringsdatum | 2 november 2021 |
| Distributiebeleid | Accumulerend |
| Distributiefrequentie | - |
| Vestigingsplaats van het fonds | Ierland |
| Fondsaanbieder | Global X |
| Fondsstructuur | Company With Variable Capital (SICAV) |
| UCITS-conformiteit | Yes |
| Administrateur | SEI Investments – Global Fund Services Limited |
| Beleggingsadviseur | |
| Bewaarbank | SEI Investments – Depositary and Custodial Services (Ireland) Limited |
| Revisiebedrijf | PwC |
| Einde belastingjaar | 30 juni |
| Vertegenwoordiger van Zwitserland | 1741 Fund Solutions AG |
| Zwitserse uitbetalende instantie | Tellco AG |
| Duitsland | 30% belastingvermindering |
| Zwitserland | ESTV Reporting |
| Oostenrijk | Belastingrapportagefonds |
| UK | UK-rapportage |
| Italië | 26,0% |
| Indextype | Totale rendementsindex |
| Swap tegenpartij | - |
| Collateral manager | |
| Effectenlening | Yes |
| Tegenpartij die effecten uitleent |
Vergelijkbare ETF
In dit gedeelte vind je informatie over andere ETF met een vergelijkbare beleggingsfocus als de Global X Genomics & Biotechnology UCITS ETF
Vergelijkbare ETF via beleggingsgidsen
Wat vind je van ons ETF-profiel? Here you'll find our Questionnaire.
Bedrijven
Hieronder vind je informatie over de samenstelling van de Global X Genomics & Biotechnology UCITS ETF
Top 10 holdings
Weging van top 10-holdings
van 49
51,60%
| Moderna, Inc. | 7,60% |
| Arrowhead Pharmaceuticals | 7,19% |
| Praxis Precision Medicine | 6,78% |
| Illumina, Inc. | 5,20% |
| Guardant Health | 4,74% |
| BioMarin Pharmaceutical | 4,29% |
| Vertex Pharmaceuticals | 4,17% |
| Natera | 4,15% |
| BioNTech SE | 4,04% |
| Bio-Techne | 3,44% |
Landen
| Verenigde Staten | 75,24% |
| Duitsland | 4,04% |
| Zwitserland | 3,33% |
| Verenigd Koninkrijk | 2,28% |
| Anders | 15,11% |
Sectoren
| Gezondheidszorg | 88,50% |
| Anders | 11,50% |
Vanaf 29/04/2026
Prestaties
Rendementsoverzicht
| YTD | +16,62% |
| 1 maand | +19,56% |
| 3 maanden | +19,73% |
| 6 maanden | +13,82% |
| 1 jaar | +60,12% |
| 3 jaar | -1,59% |
| 5 jaar | - |
| Since inception | -40,62% |
| 2025 | +5,17% |
| 2024 | -10,84% |
| 2023 | -11,72% |
| 2022 | -32,85% |
Maandelijks rendement in een heat map
Risico
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risico-overzicht
| Volatiliteit 1 jaar | 36,74% |
| Volatiliteit 3 jaar | 33,28% |
| Volatiliteit 5 jaar | - |
| Rendement/Risico 1 jaar | 1,64 |
| Rendement/Risico 3 jaar | -0,02 |
| Rendement/Risico 5 jaar | - |
| Maximaal waardedaling 1 jaar | -25,61% |
| Maximaal waardedaling 3 jaar | -45,12% |
| Maximaal waardedaling 5 jaar | - |
| Maximaal waardedaling sinds aanvang | -67,11% |
Voortschrijdende volatiliteit over 1 jaar
Beurs
Beursnoteringen
| Beursnotering | Handelsvaluta | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | GN0M | - - | - - | - |
| Borsa Italiana | EUR | GNOM | GNOM IM | ||
| Frankfurt Stock Exchange | EUR | - | GHCO/Virtu | ||
| Borsa Italiana | EUR | - | GNOMEUIV | GNOM.MI | GHCO/Virtu |
| London Stock Exchange | USD | GNOM | GNOM LN GNOMUSIV | GNOM.L GNOMiv.P | GHCO/Virtu |
| London Stock Exchange | GBP | GNOG | GNOG LN GNOMGBIV | GNOG.L | GHCO/Virtu |
| SIX Swiss Exchange | CHF | GNOM | GNOM SW GNOMCHIV | GNOM.S | GHCO/Virtu |
| Xetra | EUR | GN0M | GN0M GY GNOMEUIV | GN0M.DE | GHCO/Virtu |
Meer informatie
Nieuwste artikelen
Veelgestelde vragen
What is the name of GNOM?
The name of GNOM is Global X Genomics & Biotechnology UCITS ETF.
What is the ticker of Global X Genomics & Biotechnology UCITS ETF?
The primary ticker of Global X Genomics & Biotechnology UCITS ETF is GNOM.
What is the ISIN of Global X Genomics & Biotechnology UCITS ETF?
The ISIN of Global X Genomics & Biotechnology UCITS ETF is IE00BM8R0N95.
What are the costs of Global X Genomics & Biotechnology UCITS ETF?
The total expense ratio (TER) of Global X Genomics & Biotechnology UCITS ETF amounts to 0,50% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.
Is Global X Genomics & Biotechnology UCITS ETF paying dividends?
Global X Genomics & Biotechnology UCITS ETF is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.
What's the fund size of Global X Genomics & Biotechnology UCITS ETF?
The fund size of Global X Genomics & Biotechnology UCITS ETF is 28m Euro. See the following article for more information about the size of ETFs.
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.
Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing). Er is geen garantie voor de volledigheid, juistheid en correctheid van de getoonde informatie.